Human Molecular Genetics Advance Access published online on September 25, 2006
Human Molecular Genetics, doi:10.1093/hmg/ddl401
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Section of Cancer Genetics, Institute of Cancer Research, Surrey, UK
* To whom correspondence should be addressed. To identify low penetrance susceptibility alleles for colorectal cancer (CRC), we genotyped 1,467 non-synonymous SNPs mapping to 871 candidate cancer genes in 2,575 cases and 2,707 controls. nsSNP selection was biased towards those predicted to be functionally deleterious. One SNP, AKAP9 M463I remained significantly associated with CRC risk after stringent adjustment for multiple testing. Further SNPs associated with CRC risk included several previously reported to be associated with cancer risk including ATM F858L (OR = 1.48; 95% CI: 1.06-2.07) and P1054R (OR = 1.42; 95% CI: 1.14-1.77) and MTHFR A222V (OR=0.82; 95%CI: 0.69-0.97). To validate associations we performed a kin-cohort analysis on the 14,704 first-degree relatives of cases for each SNP associated at the 5% level in the case-control analysis employing the marginal maximum likelihood method to infer genotypes of relatives. Our observations support the hypothesis that inherited predisposition to CRC is in part mediated through polymorphic variation and identify a number of SNPs defining inter-individual susceptibility. We have made data from this analysis publically available at http://www.icr.ac.uk/research/research_sections/cancer_genetics/cancer_genetics_teams/molecular_and_population_genetics/software_and_databases/index.shtml in order to facilitate the identification of low penetrance CRC susceptibility alleles through pooled analyses.
Received August 8, 2006
Revised September 20, 2006
Accepted September 20, 2006
Article
Search for low penetrance alleles for colorectal cancer through a scan of 1,467 non-synonymous SNPs in 2,575 cases and 2,707 controls with validation by kin-cohort analysis of 14,704 first-degree relatives
Emily L Webb 1, Matthew F Rudd 1, Gabrielle S Sellick 1, Rachid El Galta 1, Lara Bethke 1, Wendy Wood 1, Olivia Fletcher 2, Stephen Penegar 1, Laura Withey 1, Mobshra Qureshi 1, Nichola Johnson 2, Ian Tomlinson 3, Richard Gray 4, Julian Peto 5, and Richard S Houlston 6 *
2 The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
3 Molecular and Population Genetics Laboratory, Cancer Research UK, London, UK
4 Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK
5 Non-Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, London, UK; and Institute of Cancer Research, Surrey, UK
6 Section of Cancer Genetics, Brookes Lawley Building, Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK
Richard S Houlston, E-mail: Richard.Houlston{at}icr.ac.uk
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Curtin, W.-Y. Lin, R. George, M. Katory, J. Shorto, L. A. Cannon-Albright, G. Smith, D. T. Bishop, A. Cox, N. J. Camp, et al. Genetic Variants in XRCC2: New Insights Into Colorectal Cancer Tumorigenesis Cancer Epidemiol. Biomarkers Prev., September 1, 2009; 18(9): 2476 - 2484. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Frank, M. Wiestler, S. Kropp, K. Hemminki, A. B. Spurdle, C. Sutter, B. Wappenschmidt, X. Chen, J. Beesley, J. L. Hopper, et al. Association of a Common AKAP9 Variant With Breast Cancer Risk: A Collaborative Analysis J Natl Cancer Inst, March 19, 2008; 100(6): 437 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hazra, S. Chanock, E. Giovannucci, D. G. Cox, T. Niu, C. Fuchs, W. C. Willett, and D. J. Hunter Large-Scale Evaluation of Genetic Variants in Candidate Genes for Colorectal Cancer Risk in the Nurses' Health Study and the Health Professionals' Follow-up Study Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Sellick, R. Wade, S. Richards, D. G. Oscier, D. Catovsky, and R. S. Houlston Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis Blood, February 1, 2008; 111(3): 1625 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Johnson, O. Fletcher, C. Palles, M. Rudd, E. Webb, G. Sellick, I. dos Santos Silva, V. McCormack, L. Gibson, A. Fraser, et al. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility Hum. Mol. Genet., May 1, 2007; 16(9): 1051 - 1057. [Abstract] [Full Text] [PDF] |
||||



